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http://intl.elsevierhealth.com/journals/ijidSHV-5 extended-spectrum beta-lactamase from
Klebsiella pneumoniae associated with a nosoco-
mial outbreak in a paediatric oncology unit in
MalaysiaOutbreaks of infections in hospitals due to
extended-spectrum b-lactamase (ESBL)-producing
strains of Klebsiella pneumoniae have been
described previously. Most have occurred in inten-
sive care units, oncology units and geriatric or
chronic care facilities.1 In the University of Malaya
Medical Centre (UMMC), Kuala Lumpur, sporadic
infections with ESBL-producing strains of K. pneu-
moniae in the paediatric oncology unit have been
described since 1990.2 However, during a four-week
period between December 1997 and January 1998,
the first documented outbreak of ESBL-producing K.
pneumoniae occurred in the 28-bed paediatric
oncology unit of the hospital and has been pre-
viously described.3 The index case was a seven-
year-old boy from whom multidrug-resistant Kleb-
siella pneumoniae (MRKP) was isolated from blood
culture and rectal swab. Following his admission to
the ward, four other patients developed phenoty-
pically similar MRKP septicaemia.3 The outbreak of
MRKP appeared to involve the emergence of several
resistant strains that, based on their pulsed-field gel
electrophoresis (PFGE) patterns,3 were thought not
to be clonal in origin.
In this follow-up study on the strains obtained
during the outbreak, the characterization of the
prevalent ESBL enzyme is described. Eight of the
nine strains that were isolated during the outbreak
were available. All of them produced the SHV-5 type
of ESBL enzyme but in addition four of them
expressed b-lactamases indicative of the SHV-1 or
SHV-2 subtype. In two representative strains the
genes encoding the SHV-5 enzyme were located
on large molecular weight plasmids of 100 kb sug-
gesting plasmid-mediated transfer of ESBL enzymes.
The strainswere isolated between December 1997
and January 1998 and included four strains from1201-9712/$30.00 # 2005 International Society for Infectious Diseas
doi:10.1016/j.ijid.2004.07.005blood cultures of the four patients with septicaemia
(samples B 1 to B 4) and two strains from rectal swabs
of two other long-term inpatients screened for
enteric carriage during the outbreak (samples RS 1
and RS 3).3 In the initial study, a total of 12 long-term
patients had been screened for enteric carriage and
three of them were carriers of ESBL-producing K.
pneumoniae.3 Two strains were obtained from two
positive samples of in-use diluted liquid soap solution
(Environmental samplesEnv1andEnv2).3 The strains
were resistant to ceftazidime, cefotaxime, ceftriax-
one and aztreonam (MICs ranging between 8 mg/ml—
256 mg/ml) but susceptible to imipenem (MICs
0.25 mg/ml—0.5 mg/ml). Phenotypic confirmation
of ESBL production and plasmid profiling has been
previously reported.3 The strains carried one ormore
plasmids of varying molecular weights (MW) from
1.5 kb—150 kb in size and all carried at least one high
MW plasmid with a molecular size of 150, 100, 80, 60
and34 kb.3 However, the100 kbplasmidwas found to
beprevalent in thepatient-derived isolates. Crudeb-
lactamase extract for isoelectric focusing (IEF) was
prepared according to the method of Piddock et al.4
E. coli strains producing SHV-1 and SHV-2 with pI
values of 7.6, SHV-4 with a pI value of 7.8 and SHV-
5 with a pI value of 8.2 were used as controls. b-
lactamase enzymeswith pI values of 8.2 suggestive of
SHV-5 were present in all strains and in four of them
(strains B 3, B 4, RS 1 and RS 3) an additional b-
lactamase with a pI value of 7.6 and possibly corre-
lating to SHV-1 and SHV-2 was detected. The entire
coding regionof theSHVgenewasamplifiedusingSHV
primer sequences 50-ATGCGTTATATTCGCCTGTG-30
(F) and 50-GTTAGCGTTGCCAGTGCTCG-30 (R) produ-
cing an amplicon size of 865-bp5 correlating to the
SHVgene. The E. coliproducing SHV-1 strainwas used
as the control.
Polymerase chain reaction single strand confor-
mational polymorphism (PCR-SSCP) technique
described by M’Zali et al.6 was used to further
characterize the SHV gene. The SSCP profiles of
the samples were compared with those of control
strains producing SHV-1, SHV-2, SHV-4 and SHV-5.es. Published by Elsevier Ltd. All rights reserved.
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Figure 1 SSCP-profile of the control strains and some of the outbreak strains. Lane 1: SHV-1; Lane 2: SHV-2; Lane 3: SHV-
4; Lane 4: SHV-5; Lane 5: B 1; *Lane 6: RS 1; Lane 7: Env 1. *Strain RS 1 had an extra band suggesting an additional SHV
enzyme.SHV enzymes with a pI value of 8.2 showed a similar
SSCP profile with that of the SHV-5 control strain
suggesting that these enzymes were SHV-5. This was
confirmed via nucleotide sequencing of the entire
coding region of the SHV gene from a representative
strain B 2. (GenBank accession number AY155194)
The nucleotide sequence obtained was homologous
to the DNA sequence of blaSHV-5 accession number
X55640 K. pneumoniae SHV-5 plasmid, giving a 99%
homology and 100% homology with its deduced
amino acid sequence (Figure 1). The SHV-5 b-lacta-
mase gene being detected in all the isolates, prob-
ably accounted for the ESBL phenotype of the
strains, thus characterization of the enzyme with
a pI value of 7.6 that was present in only four strains
was not carried out.
A 100 kb plasmid was found in four of the six
patient-derived isolates and it was postulated that
the SHV-5 gene would be present in these plasmids.
DNA hybridization was carried out on two represen-
tative strains, RS 1 and RS 3, using the conventional
Southern Hybridization technique.7 The strains
were selected randomly from patient-derived iso-
lates which harbored a 100 kb plasmid. Plasmid DNA
was extracted by the method of Kado and Liu8 and
probed with an intragenic SHV probe specific to the
SHV-5 b-lactamase.6 The probe hybridized with
large plasmids of 100 kbmolecular weight indicating
that the SHV-5 gene was present on the higher
molecular weight plasmids and not on plasmids witha molecular weight of 3 kb and 1.8 kb that were also
present in RS 1 and RS 3.
ESBL-producing K. pneumoniae have emerged as
important nosocomial pathogens in the UMMC and
the prevalent ESBL enzyme produced in sporadic
isolates studied between 1995 and 1996 was of the
SHV-5 subtype.9 Although SHV-5 ESBL enzymes asso-
ciated with outbreaks have been described pre-
viously in other countries such as the UK and
France10 this has not been previously described in
Malaysia. The nosocomial spread of ESBL-mediated
antibiotic resistance in Klebsiella may be due to the
clonal spread of the organism or by transfer of
plasmids encoding ESBL genes. According to earlier
studies the clonal spread of ESBL-producing Kleb-
siella was not evident but it now seems likely that
SHV-5 gene was being disseminated in the hospital
environment by plasmid transfer.Acknowledgements
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